Unknown OBSERVATIONAL NCT03884179

Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Diagnosis of Pancreatic Cystic Lesions With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Sponsor: Sahlgrenska University Hospital

Conditions Pancreatic Cyst Pancreatic Cystadenocarcinoma Pancreatic Intraductal Papillary-Mucinous Neoplasm Pancreatic Mucinous Cystadenoma Pancreatic Neuroendocrine Carcinoma Pancreatic Pseudocyst Pancreatic Serous Cystadenoma Solid Pseudopapillary Tumor of the Pancreas

Updated 7 times since 2019 Last updated: Mar 19, 2019 Started: Feb 1, 2007 Primary completion: Dec 1, 2017 Completion: Mar 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pancreatic Cyst and Pancreatic Cystadenocarcinoma, this trial is ongoing. The trial is conducted by Sahlgrenska University Hospital and has accumulated 7 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Unknown
Feb 2025 — Mar 2025 [monthly]

Unknown
Sep 2024 — Feb 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting
Apr 2019 — Jan 2021 [monthly]

Active Not Recruiting

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sahlgrenska University Hospital

Data source: Sahlgrenska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.